Chest:非肺脏累及的肺外结节病临床特点分析!

2018-02-20 xing.T MedSci原创

由此可见,肺脏累及和非肺脏累及结节病患者有显著的人口统计学和性别差异。这些差异反映了以前关于皮肤和肺部累及结节病患者之间的差异,因为皮肤是NPS累及的主要器官。虽然肺脏很可能是肺结节病的主要暴露部位,但在NPS中皮肤受累率很高,表明皮肤是呼吸道外抗原捕获最有利的部位。

相比于肺结节病,不累即肺脏的结节病可能参与其他的免疫病理机制以及与其他人口统计学和临床特征有关。近日,呼吸领域权威杂志chest上针对这一问题发表了一篇研究文章。

该研究是一项对1686例来自于美国两所大学大型结节病门诊的经活检证实的结节病患者的实时临床资料进行的回顾性分析。研究人员比较了肺脏累及和非肺脏累及结节病患者的人口统计学特征和临床表现的差异。只有在正常的胸部成像并且根据目前公认的标准没有肺部受累特征的情况下,才被认为非肺脏累及结节病(NPS)。

研究人员发现8.3%的结节病队列患者符合NPS标准。NPS在白种人患者中比黑人患者更为常见,在女性中比男性更常见。皮肤是最常见的累及器官,可在近一半的NPS患者中观察到皮肤受累。孤立性皮肤结节病是NPS组最常见的器官受累形式(25%),5%以上的NPS患者无其他受累形式。

由此可见,肺脏累及和非肺脏累及结节病患者有显著的人口统计学和性别差异。这些差异反映了以前关于皮肤和肺部累及结节病患者之间的差异,因为皮肤是NPS累及的主要器官。虽然肺脏很可能是肺结节病的主要暴露部位,但在NPS中皮肤受累率很高,表明皮肤是呼吸道外抗原捕获最有利的部位。
 
原始出处:

W. Ennis James,et al. Clinical Features of Extrapulmonary Sarcoidosis without Lung Involvement.chest.2018. https://doi.org/10.1016/j.chest.2018.02.003

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1632956, encodeId=2dd91632956ce, content=<a href='/topic/show?id=f0ad821030c' target=_blank style='color:#2F92EE;'>#肺外结节病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82103, encryptionId=f0ad821030c, topicName=肺外结节病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=029f21960093, createdName=zhenjiu130, createdTime=Mon Aug 27 12:53:00 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1929470, encodeId=732b19294e092, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Fri Feb 23 15:53:00 CST 2018, time=2018-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051064, encodeId=89932051064a5, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Nov 22 19:53:00 CST 2018, time=2018-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933887, encodeId=450e193388e96, content=<a href='/topic/show?id=7c1c2288877' target=_blank style='color:#2F92EE;'>#临床特点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22888, encryptionId=7c1c2288877, topicName=临床特点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Sat Nov 24 08:53:00 CST 2018, time=2018-11-24, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1632956, encodeId=2dd91632956ce, content=<a href='/topic/show?id=f0ad821030c' target=_blank style='color:#2F92EE;'>#肺外结节病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82103, encryptionId=f0ad821030c, topicName=肺外结节病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=029f21960093, createdName=zhenjiu130, createdTime=Mon Aug 27 12:53:00 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1929470, encodeId=732b19294e092, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Fri Feb 23 15:53:00 CST 2018, time=2018-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051064, encodeId=89932051064a5, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Nov 22 19:53:00 CST 2018, time=2018-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933887, encodeId=450e193388e96, content=<a href='/topic/show?id=7c1c2288877' target=_blank style='color:#2F92EE;'>#临床特点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22888, encryptionId=7c1c2288877, topicName=临床特点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Sat Nov 24 08:53:00 CST 2018, time=2018-11-24, status=1, ipAttribution=)]
    2018-02-23 Smile2680
  3. [GetPortalCommentsPageByObjectIdResponse(id=1632956, encodeId=2dd91632956ce, content=<a href='/topic/show?id=f0ad821030c' target=_blank style='color:#2F92EE;'>#肺外结节病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82103, encryptionId=f0ad821030c, topicName=肺外结节病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=029f21960093, createdName=zhenjiu130, createdTime=Mon Aug 27 12:53:00 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1929470, encodeId=732b19294e092, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Fri Feb 23 15:53:00 CST 2018, time=2018-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051064, encodeId=89932051064a5, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Nov 22 19:53:00 CST 2018, time=2018-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933887, encodeId=450e193388e96, content=<a href='/topic/show?id=7c1c2288877' target=_blank style='color:#2F92EE;'>#临床特点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22888, encryptionId=7c1c2288877, topicName=临床特点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Sat Nov 24 08:53:00 CST 2018, time=2018-11-24, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1632956, encodeId=2dd91632956ce, content=<a href='/topic/show?id=f0ad821030c' target=_blank style='color:#2F92EE;'>#肺外结节病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82103, encryptionId=f0ad821030c, topicName=肺外结节病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=029f21960093, createdName=zhenjiu130, createdTime=Mon Aug 27 12:53:00 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1929470, encodeId=732b19294e092, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Fri Feb 23 15:53:00 CST 2018, time=2018-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051064, encodeId=89932051064a5, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Nov 22 19:53:00 CST 2018, time=2018-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933887, encodeId=450e193388e96, content=<a href='/topic/show?id=7c1c2288877' target=_blank style='color:#2F92EE;'>#临床特点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22888, encryptionId=7c1c2288877, topicName=临床特点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Sat Nov 24 08:53:00 CST 2018, time=2018-11-24, status=1, ipAttribution=)]